below both Drake’s and Lynch’s products, the price of deleterious mutations is what drives mutation charges down (Drake 1991; Lynch 2010; Sung et al. 2012). Therefore, below both of those versions, an increase in the normal price of mutations would bring on a minimize in mutation fees. To examine this, Drake examined mutation premiums of thermo